Evidence map›Paper›PMID 39991438›Full record

ArticleMethodsX2025

Industrial wastewater treatment and reuse: Heckman probit sample selection model.

Urgessa Tilahun Bekabil, M K Jayamohan, Amsalu Bedemo Beyene

Abstract read
In one paragraph

Article in MethodsX, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Urgessa Tilahun BekabilCollege of Business and Economics, Jimma University, Jimma, Ethiopia.
M K JayamohanCollege of Business and Economics, Jimma University, Jimma, Ethiopia.
Amsalu Bedemo BeyeneSchool of Policy Studies, Ethiopian Civil Service University, Addis Ababa, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wastewater treatment and reuse help emerging economies to minimize their water scarcity. This study examines the factors influencing wastewater treatment and reuse by manufacturing firms in Shaggar City. The Heckman Probit Sample Selection model is used to analyse the data collected from 303 randomly selected manufacturing firms using structured questionnaires. Results revealed that R&D costs, innovation practices, the availability of purpose-driven vehicles for waste transport, energy costs, and the scale of operations significantly affect the reuse of treated wastewater. The result also shown that presence of wastewater treatment facilities, energy costs, R&D costs, and existence of solid waste disposal facilities were found to be statistically significant in determining wastewater treatment decision. The result implies that firms with treatment and disposal facilities take a more active approach to adopting sustainable techniques as their energy costs and R&D investment rise. Policymakers and industrial firms should think about ways to educate and encourage firms and the surrounding community to reuse treated wastewater, which promotes water conservation and reduces urban water scarcity.•The Heckman Probit Selection model effectively identifies and analyzes the factors influencing wastewater treatment and reuse in the industrial sector.•Implementing wastewater treatment solutions is crucial for minimizing water shortages in urban areas of emerging economies.•The estimated model highlights the essential actions to be taken for achieving a sustainable environment.

Indexed as

Environmental sustainabilityIndustrialisationIndustrial Wastewater Treatment and Reuse: Heckman Probit Sample Selection ModelManufacturing firmsSample selectionWastewater treatment

Identifiers

PMID39991438
PMCPMC11847467

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.